Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus

NeuroImage

Volumn 34, Issue 2, 2007, Pages 694-701

  Appenzeller, Simone ^a   Bonilha, Leonardo ^b   Rio, Pablo A ^a   Min Li, Li ^a   Costallat, Lilan Tereza Lavras ^a   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Gray matter; MRI; SLE; VBM; White matter

Indexed keywords

CORTICOSTEROID; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ADULT; ARTICLE; BRAIN ATROPHY; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BRAIN; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TIME FACTORS;

EID: 37849185644     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.09.029     Document Type: Article

References (48)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42 (1999) 599-608
2. Adelmann D.C., Saltiel E., and Klinenberg J.R. The neuropsychiatric manifestations of SLE: an overview. Semin. Arthr. Rheum. 15 (1986) 185-199
3. Appenzeller S., Rondina J.M., Li L.M., Costallat L.T., and Cendes F. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum. 52 (2005) 2783-2789
4. Ashburner J., and Friston K.J. Voxel-based morphometry-The method. NeuroImage 11 (1997) 805-821
5. Ashburner J., and Friston K.J. Multimodal image coregistration and partitioning-A unified framework. NeuroImage 6 (2000) 209-217
6. Ashburner J., Neelin P., Collins D.L., Evans A.C., and Friston K. Incorporating prior knowledge into imaging registration. NeuroImage (2001) 344-352
7. Baum K.A., Hopf U., Nehrig C., Stover M., and Schorner W. Systemic lupus erythematosus: neuropsychiatric signs and symptoms related to cerebral MRI findings. Clin. Neurol. Neurosurg. 95 (1993) 29-34
8. Beck A.T., and Beamesderfer A. Assessment of depression: the depression inventory. Mod. Probl. Pharmacopsychiatry 7 (1993) 151-169
9. Beck A.T., Rial W.Y., and Rickels K. Short form of depression inventory: cross-validation. Psychol. Rep. 34 (1974) 1184-1186
10. Bjartmar C., and Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanism and functional consequences. Curr. Opin. Neurol. 14 (2001) 271-278
11. Black S.E., Moffat S.D., Yu D.C., et al. Callosal atrophy correlates with temporal lobe volume and mental status in Alzheimer's disease. Can. J. Neurol. Sci. 27 (2000) 204-209
12. Bombardier C., Gladman D.D., Urowitz M., Caron D., and Chang C. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 35 (1992) 630-640
13. Carette S., Urowitz M.B., Grosman H., and St Louis E.L. Cranial computerized tomography in systemic lupus erythematosus. J. Rheumatol. 9 (1982) 855-859
14. Chinn R.J., Wilkinson I.D., Hall-Craggs M.A., et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 36-46
15. Cotton F., Bouffard-Vercelli J., Hermier M., et al. MRI of central nervous system in a series of 58 systemic lupus erythematosus (SLE) patients with or without overt neuropsychiatric manifestations. Rev. Med. Interne 25 (2004) 8-15
16. Csepany T., Bereczki D., Kollar J., et al. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension. J. Neurol. 250 (2003) 1348-1354
17. Delis D.C., Kramer J.H., Kaplan E., et al. California Verbal Learning Test Research Edition Manual (1987), The Psychological Corporation, San Antonio
18. Denburg S.D., and Denburg J.A. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 12 (2003) 883-890
19. Evangelou N., Esiri M.M., Smith S., Palace J., and Matthews P.M. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann. Neurol. 47 (2000) 391-395
20. Feinglass E.J., Arnett F.C., Dorsh C.A., Zizic T.M., and Stevens M.B. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum and relationship to the other features of the disease. Medicine 55 (1976) 323-339
21. Folstein M.F., Folstein S.E., and Folstein P.R. "Mini mental state": a practical method for grading the cognitive state of patient for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
22. Fox N.C., Jenkins R., Leary S.M., Stevenson V.L., et al. Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 54 (2000) 807-812
23. Friston K.J., Holmes A.P., Worsley K.P., et al. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 2 (1995) 189-210
24. Genovese C.R., Lazar N.A., and Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. NeuroImage 15 (2002) 870-878
25. Gladman D.D., Urowitz M.B., Goldsmith C.H., et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 40 (1997) 809-813
26. Good C.D., Johnsrude I.S., and Ashburner J. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14 (2001) 21-36
27. Hachulla E., Michon-Pasturel U., Leys D., and Pruvo J.P. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 7 (1998) 24-31
28. Hampel H., Teipel S.J., Alexander G.E., et al. Corpus callosum atrophy is a possible indicator of region-and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Arch. Neurol. 55 (1998) 193-198
29. Heaton R.K., Chelune G.J., Talley J.L., et al. Wisconsin Card Sorting Test Manual, Revised and Expanded (1993), Psychological Assessment Resources, Inc., Odessa
30. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-A review of validation data and clinical results. J. Psychosom. Res. 42 (1997) 17-41
31. Huizinga T.W., Steens S.C., and van Buchem M.A. Imaging modalities in central nervous system systemic lupus erythematosus. Curr. Opin. Rheumatol. 13 (2001) 383-388
32. Janowsky J.S., Kaye J.A., and Carper R.A. Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. J. Am. Geriatr. Soc. 44 (1996) 798-803
33. Leys D., Pruvo J.P., Parent M., et al. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder?. J. Neurol., Neurosurg. Psychiatry 54 (1991) 46-50
34. Lezak M.D. Neuropsychological Assessment (1995), Oxford Univ. Press, New York
35. Losseff N.A., Wang L., Lai H.M., et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 119 (1996) 2009-2019
36. Omdal R., Selseth B., Klow N.E., Husby G., and Mellgren S.I. Clinical neurological, electrophysiological, and cerebral CT scan findings in systemic lupus erythematosus. Scand. J. Rheumatol. 18 (1989) 283-289
37. Overall J.E., and Beller S.A. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J. Gerontol. 39 (1984) 187-193
38. Rorden C., and Brett M. Stereotaxic display of brain lesions. Behav. Neurol. 12 (2000) 191-200
39. Rudick R.A., Fischer E., Lee J.C., Simon J., and Jacobs L. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 53 (1999) 1698-1704
40. Sibbitt Jr.W.L., Sibbitt R.R., Griffey R.H., Eckel C., and Bankhurst A.D. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann. Rheum. Dis. 48 (1989) 1014-1022
41. Smith S.M., Zhang Y., Jenkinson M., et al. Accurate, robust and automated longitudinal and cross-sectional brain changes analysis. NeuroImage 17 (2002) 479-489
42. Spranoel H.Z. The Psychoeducational Use and Interpretation of the Wechsler Adult Intelligence Scale-Revised (1992), CC Thomas, Springfield
43. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
44. Waterloo K., Omdal R., Jacobsen E.A., Klow N.E., Husby G., Torbergsen T., et al. Cerebral computed tomography and electroencephalography compared with neuropsychological findings in systemic lupus erythematosus. J. Neurol. 246 (1999) 706-711
45. Wechsler. Muistiasteikko, Suom. Anja Manner (1986), Psykologien Kustannus, Helsinki
46. Weisberg L.A. The cranial computed tomographic findings in patients with neurologic manifestations of systemic lupus erythematosus. Comput. Radiol. 10 (1986) 63-68
47. Yamanoushi H., Fukuyama H., Harada K., et al. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. Arch. Neurol. 50 (1993) 1070-1074
48. Zanardi V.A., Magna L.A., and Costallat L.T. Cerebral atrophy related to corticotherapy in systemic lupus erythematosus (SLE). Clin. Rheumatol. 20 (2001) 245-250